Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-16T12:35:21.201Z Has data issue: false hasContentIssue false

Intensive Cortisone Therapy in Schizophrenia

Published online by Cambridge University Press:  08 February 2018

Linford Rees
Affiliation:
Bethlem Royal and Maudsley Hospitals
G. M. King
Affiliation:
St. Cadoc's Hospital, Caerleon
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Cortisone therapy has been claimed to produce favourable results in clinical schizophrenics (Cohn and Karnosh, 1951; Cohn et al., 1953). Rees and King (1952) carried out a controlled investigation on the effects of Cortisone given in moderate doses over a four-day period to a group of schizophrenic patients and found no significant changes in symptomatology, behaviour or in a series of psychological and physiological tests.

In a personal communication Dr. Cohn suggested that Cortisone given in higher doses over a longer period would probably be therapeutically more effective in chronic schizophrenia.

The present paper describes a controlled investigation into the therapeutic effects of Cortisone given in high dosage over a relatively prolonged period.

Information

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1956 
Submit a response

eLetters

No eLetters have been published for this article.